Keros Therapeutics Inc (KROS)

Investing Cash Flow

-$494.00K

TTM · Period ending: · USD

KROS logo

KROS Investing Cash Flow

Latest reported-$494.00K
KROS TTM Cash from Investing (-$271.00K → -$494.00K)
High-resolution chart · PNG

KROS investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Keros Therapeutics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-494,000
-1,059,000
-1,551,000
-1,706,000
-1,960,000
-1,550,000
-1,931,000
-2,183,000
-2,347,000
-2,348,000
-2,464,000
-2,274,000
-1,900,000
-2,156,000
-1,241,000
-1,049,000
-1,018,000
-961,000
-1,024,000
-925,000
-810,000
-328,000
-294,000
-252,000
-304,000
-447,000
-271,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.